(ONLINE CONTENT)
2022 MPHP Prescriber Summit on Controlled Substances
Thank you all for choosing the MPHP 2022 Prescriber Summit! We hope that you find the presentations informative and helpful for your practices.
Please watch all five (5) videos for full credit. Once you have watched all five, please fill out the CME Claim form and the Evaluation. When we have received both forms and have verified registration, we will email your CME certificate.
In compliance with the ACCME/MSMA Standards for Commercial Support of CME, our speakers have asked me to advise you that they have no relevant financial relationships to disclose. Planners of this activity were also asked to disclose relevant financial relationships concerned with the content of this activity and they have nothing to disclose.
Speakers and Topics
Ken Cleveland, M.D.
Executive Director, MS State Board of Medical Licensure
Rules and Regulations Update
Scott Hambleton, M.D., D.F.A.S.A.M.
Medical Director, Molina Healthcare
Principles of Prescribing Controlled Substances
Saurabh B. Bhardwaj, M.D.
Medical Director, Center for Innovation & Discovery in Addictions
Prescribing Challenges in Dual Diagnosis Patients
J. Anthony Cloy, M.D.
Medical Director, Mississippi Physician Health Program
Revisiting CDC Guidelines on Prescribing Controlled Substances
Kenneth Cleveland, M.D., a native of Alabama completed his residency at the University of Mississippi Medical Center as Chief Surgical Resident in 2001. He since has practiced medicine in Mississippi in surgical and administrative capacities. He comes to the Mississippi Board of Medical Licensure from Remedy True Health, where he served as the owner, CEO and primary physician. His background brings a wealth of knowledge in both medicine and management.
Dr. Hambleton is a 1994 graduate of the University of Tennessee School of Medicine. He completed the Accelerated Family Practice Residency at the University of Tennessee in 1996 and the University of Florida Addiction Medicine Fellowship at Pine Grove Behavioral Health in Hattiesburg, Mississippi, in 2007. Dr. Hambleton is President-Elect of the Federation of State Physician Health Programs and is board certified by the American Board of Family Medicine and the American Board of Preventative Medicine in Addiction Medicine. He is a Distinguished Fellow in the American Society of Addiction Medicine, and a certified Medical Review Officer. Dr. Hambleton served as Medical Director of the Mississippi Physician Health Program from 2010-2021 and currently serves as Chair of the Mississippi Physician Health Committee.
Medical Director of the Addictions Program is board-certified in both general psychiatry and addiction psychiatry. Dr. Bhardwaj received his medical degree from Dr. Vaishampayan Memorial Medical College in Solapur, India, then went on to complete an internship in medicine, surgery, and related branches at Grant Medical College and J.J. Group of Hospitals, Mumbai, India. In 2017, Dr. Bhardwaj completed a general adult psychiatry residency program at the University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, Pennsylvania followed by an addiction psychiatry fellowship at Northwestern University, McGaw Medical Center, Feinberg School of Medicine in Chicago. Dr. Bhardwaj’s passion for addictions treatment lead him to UMMC in August of 2018 to be medical director of the then new addiction clinic where he introduced new, evidenced based, methods of addictions care. Dr. Bhardwaj is the medical director of the new Center for Innovation & Discovery in Addiction or CIDA. When Dr. Bhardwaj is not seeing patients or doing research, he enjoys spending time with family, tending to his vegetable garden, or peering through his telescope at nebulae, star clusters, and planets.
J. Anthony Cloy, M.D., earned his medical degree from the University of Mississippi School of Medicine in 1991 and completed a Family Medicine residency there in 1994. After seven years of traditional practice, he returned as faculty in the Family Medicine Department at UMMC in 2001 where he rose to the rank of Associate Professor. While at UMMC, he participated in the organization’s Opioid Task Force and Controlled Substance education series. Dr. Cloy is a diplomate of the American Board of Family Medicine and is a member of AAFP, STFM, AMA, and ASAM. He is past president and secretary of the Mississippi Society of Addiction Medicine and has served on the planning committee for the Mississippi Addictions Conference. As a member of the Mississippi Physician Health Committee, he served as chair prior to his appointment as Mississippi Physician Health Program Medical Director in 2021.